-transparent.png){kind=logo}
Monocytopoiesis and blood monocytes were investigated in patients with superficial spreading melanoma stages I and II. Monocyte production was moderately increased in 4 of 9 untreated patients. Postoperative prophylactic BCG-vaccination gave rise to increased proliferation activity in 3 of 4 patients with previously normal monocytopoiesis. However, monocyte production returned to normal between the 4th and 6th month of BCG immunotherapy. Monocytopoietic hyperproliferation did not occur if DTIC was administered simultaneously with BCG. These results indicate that BCG-vaccination increases monocytopoiesis during the first months of treatment only. This effect is abrogated by concomitant chemotherapy.
E Schmitt, and
G Meuret, and
F Waldermann, and
M Hagedorn
January 1975,
The New England journal of medicine,
E Schmitt, and
G Meuret, and
F Waldermann, and
M Hagedorn
August 1993,
Melanoma research,
E Schmitt, and
G Meuret, and
F Waldermann, and
M Hagedorn
January 1995,
Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer,
E Schmitt, and
G Meuret, and
F Waldermann, and
M Hagedorn
January 1991,
Dermatologica,
E Schmitt, and
G Meuret, and
F Waldermann, and
M Hagedorn
January 2007,
The Cochrane database of systematic reviews,
E Schmitt, and
G Meuret, and
F Waldermann, and
M Hagedorn
March 1982,
Journal of surgical oncology,
E Schmitt, and
G Meuret, and
F Waldermann, and
M Hagedorn
October 1976,
British medical journal,
E Schmitt, and
G Meuret, and
F Waldermann, and
M Hagedorn
January 2000,
Zentralblatt fur Chirurgie,
E Schmitt, and
G Meuret, and
F Waldermann, and
M Hagedorn
June 1999,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
E Schmitt, and
G Meuret, and
F Waldermann, and
M Hagedorn
January 1981,
Cancer treatment reports,
